Job overview
The position is a 2-3-year research fellowship intended for surgical trainees who wish to undertake predominately clinical research, which may include a higher degree, either an MD Res or PhD in surgical oncology. The post is based jointly between the Sarcoma, Melanoma and Rare Tumour (Surgical Oncology) Units in the Royal Marsden Hospital Chelsea and the Chester Beatty Laboratories in the Institute of Cancer Research. Both Institutes are on the Fulham Road in Chelsea and are within 100 metres of each other. There is possibility that some of the work may take place in the Sutton branches of both the Royal Marsden and Institute of Cancer Research but will be based at the Fulham Road site. We work closely with the CRUK Convergence Science centre.
Main duties of the job
Detailed job description and main responsibilities
The SMART Unit
The Royal Marsden Sarcoma Melanoma and Rare Tumour unit is a tertiary referral centre for complex intra- abdominal sarcomas (with special interests in retroperitoneal sarcoma, complex GIST and rare pelvic tumours), extremity sarcomas (including isolated limb perfusion), advanced cutaneous malignancies, and other rare tumours (e.g. endocrine and neuroendocrine tumours). The unit is run by three full time consultant Surgical Oncologists (Mr A J Hayes, Mr Myles Smith, Mr Dirk Strauss); 3-4 clinical fellows or registrars with 1 junior surgeon at Core trainee level, an advanced nurse practitioner and physician’s associate. There are 4-5 all day operating lists per week, with a one-half day minor ops clinic.
Person specification
Education / Qualifications
Essential criteria
1. Eligible for Registration with the GMC
Desirable criteria
2. BSc/other related degrees/qualifications
3. MRCS/FRCS or equivalent
Experience
Essential criteria
4. Completed Core Surgical Training
Desirable criteria
5. Scientific Experience from a BSc Project
Skills / Abilities/ Knowledge
Essential criteria
6. Competent to work without direct supervision where appropriate
7. Clear logical thinking, showing an analytical approach
8. Appropriate level of clinical and scientific knowledge
9. Shows awareness of own limitations
10. Demonstrates breadth of experience and awareness in and outside the speciality
Desirable criteria
11. Knowledge of coding, and comfort with technology
The Royal Marsden values diversity and is committed to the recruitment and retention of underrepresented minority groups. We particularly welcome applications from Black, Asian and minority ethnic candidates, LGBTQ+ candidates and candidates with disabilities.
As a Disability Confident Employer, we are working to create a workplace that enables all staff to reach their full potential. We are committed to this because we know that greater diversity and inclusion will lead to an even greater positive impact for the people we serve.
Due to the high volumes of applications we receive, we reserve the right to close any adverts before the published closing date once we have received a sufficient number of applications. We advise you to submit your application as early as possible to prevent disappointment.
Flu Vaccination – What We Expect of our Staff
At The Royal Marsden we have an immune compromised patient population who we must protect as much as we can against the flu virus. Each year, seasonal flu affects thousands of people in the UK. Occurring mainly in winter, it is an infectious respiratory disease capable of producing symptoms ranging from those similar to a common cold, through to very severe or even fatal disease.
The wellbeing of our staff and patients is of the upmost importance to us, and it is the expectation of The Royal Marsden that all patient-facing staff have an annual flu vaccination, provided free of charge by the Trust.
Employer certification / accreditation badges
Applicant requirements
You must have appropriate UK professional registration.
This post is subject to the Rehabilitation of Offenders Act 1974 (Exceptions) Order 1975 (Amendment) (England and Wales) Order 2020 and it will be necessary for a submission for Disclosure to be made to the Disclosure and Barring Service.